ES2127302T3 - Composiciones farmaceuticas que incluyen polimeros en silicato. - Google Patents

Composiciones farmaceuticas que incluyen polimeros en silicato.

Info

Publication number
ES2127302T3
ES2127302T3 ES94104300T ES94104300T ES2127302T3 ES 2127302 T3 ES2127302 T3 ES 2127302T3 ES 94104300 T ES94104300 T ES 94104300T ES 94104300 T ES94104300 T ES 94104300T ES 2127302 T3 ES2127302 T3 ES 2127302T3
Authority
ES
Spain
Prior art keywords
silicate
pharmaceutical compositions
compositions including
including polymers
silicate polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94104300T
Other languages
English (en)
Inventor
Jin-Emon Konishi
Giichi Hamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2127302T3 publication Critical patent/ES2127302T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Silicon Compounds (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EN EL PRESENTE INVENTO SE PRESENTA UNA COMPOSICION FARMACEUTICA QUE CONTIENE POLIMERO DE SILICATO COMO INGREDIENTE ACTIVO QUE REGULA LA FUNCION DE UN CUERPO VIVIENTE. EL POLIMERO DE SILICATO DE LA COMPOSICION PUEDE OBTENERSE MEDIANTE UN PROCESO DONDE EL ACIDO SILICICO O SILICATO SE DISUELVE EN SOLVENTE ACUOSO, AJUSTANDO SU PH ENTRE 4 Y 10, Y SECADO. EL POLIMERO DE SILICATO ASI PRODUCIDO SE USA EN LA FABRICACION DE MEDICINAS EFICACES PARA LA REGULACION DEL FUNCIONAMIENTO DE ORGANISMOS VIVOS.
ES94104300T 1993-03-19 1994-03-18 Composiciones farmaceuticas que incluyen polimeros en silicato. Expired - Lifetime ES2127302T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5085322A JP2588109B2 (ja) 1993-03-19 1993-03-19 鎮痛剤

Publications (1)

Publication Number Publication Date
ES2127302T3 true ES2127302T3 (es) 1999-04-16

Family

ID=13855390

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94104300T Expired - Lifetime ES2127302T3 (es) 1993-03-19 1994-03-18 Composiciones farmaceuticas que incluyen polimeros en silicato.

Country Status (11)

Country Link
US (3) US5534509A (es)
EP (1) EP0621038B1 (es)
JP (1) JP2588109B2 (es)
KR (2) KR100268575B1 (es)
CN (1) CN1078469C (es)
AT (1) ATE173932T1 (es)
DE (1) DE69414904T2 (es)
DK (1) DK0621038T3 (es)
ES (1) ES2127302T3 (es)
SG (1) SG45236A1 (es)
TW (1) TW270085B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
KR20010020741A (ko) * 1999-04-15 2001-03-15 고니시 진우에몬 신규의 생체 활성화 물질
CN1312080A (zh) 2000-02-18 2001-09-12 日本脏器制药株式会社 含有脂肪酸的组合物
KR100532915B1 (ko) * 2002-10-29 2005-12-02 삼성전자주식회사 단당류계 또는 올리고당류계 포로젠을 포함하는 다공성층간 절연막을 형성하기 위한 조성물
JP4145262B2 (ja) * 2004-03-23 2008-09-03 三洋電機株式会社 積層セラミック基板
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
US20100278935A1 (en) * 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
EP2151466A1 (en) * 2008-08-01 2010-02-10 SiNatur GmbH Biologically active silicic acid
DE102010008981A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
AU2011316756B2 (en) 2010-10-14 2015-01-22 Nippon Zoki Pharmaceutical Co., Ltd A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
JP2014510590A (ja) * 2011-03-31 2014-05-01 ガルデルマ・リサーチ・アンド・デベロップメント フィラー製品および少なくとも１つの生体吸収性および生分解性シリカベースの材料を含む組成物
GB201402669D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Stabilised silicate compositions and their uses
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
CN105943566A (zh) * 2016-04-21 2016-09-21 叶卫斌 水溶性硅与中药材或食材提取物之复方制剂的制备方法
EP3496728B1 (en) 2016-08-10 2021-05-26 United Kingdom Research and Innovation Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
CN110818902B (zh) * 2019-11-05 2021-11-16 塔里木大学 一种酰氧化聚硅酸化合物及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB697351A (en) * 1951-01-16 1953-09-23 Masuichi Takino Improved process for the manufacture of nerve sedatives
US3959566A (en) * 1974-10-21 1976-05-25 E. I. Du Pont De Nemours And Company Process for preparing polymeric surfaces to improve antistatic and soil resistant properties
US4036787A (en) * 1975-09-12 1977-07-19 Blount David H Process for the production of epoxy silicate compounds and polymers
US4039474A (en) * 1975-10-20 1977-08-02 Nalco Chemical Company Silica-alumina catalysts
US4056937A (en) * 1976-01-08 1977-11-08 Kyokado Engineering Co. Ltd. Method of consolidating soils
US4089883A (en) * 1976-07-09 1978-05-16 Blount David H Process for the production of organic hydroxy silicate compounds and their condensation products
US4125694A (en) * 1977-01-06 1978-11-14 Blount David H Process for the polymerization of allyl halides to form polyallyl alcohol
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS57183720A (en) * 1981-05-01 1982-11-12 Junji Mitani Health drug for fish farming
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS58121217A (ja) * 1982-01-13 1983-07-19 Takeo Kagitani 火傷薬
US4640361A (en) * 1985-12-13 1987-02-03 Halliburton Company Thermally responsive aqueous silicate mixtures and use thereof
JPS62145022A (ja) * 1985-12-18 1987-06-29 Sofuto Shirika Kk 食中毒症用薬剤
KR960009766B1 (ko) * 1986-09-10 1996-07-24 니혼 소오끼 세이야꾸 가부시기가이샤 생리 활성물질 측정법
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
US4863518A (en) * 1987-10-19 1989-09-05 Blount David H Production of polyol-alkali metal silicate glass emulsion
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
ATE94401T1 (de) * 1988-04-30 1993-10-15 Nippon Zoki Pharmaceutical Co Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
SE461156B (sv) * 1988-05-25 1990-01-15 Eka Nobel Ab Saett foer framstaellning av papper varvid formning och avvattning aeger rum i naervaro av en aluminiumfoerening, ett katjoniskt retentionsmedel och en polymer kiselsyra
JP2539665B2 (ja) * 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
EP0479218B1 (en) * 1990-10-01 1994-03-30 Suido Kiko Kabushiki Kaisha Flocculant for water treament and method for producing it
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
US5523295A (en) * 1994-07-06 1996-06-04 Brandeis University Method for treating and preventing alzheimer's disease

Also Published As

Publication number Publication date
KR100268575B1 (ko) 2000-11-01
KR940021071A (ko) 1994-10-17
ATE173932T1 (de) 1998-12-15
DE69414904T2 (de) 1999-05-12
CN1078469C (zh) 2002-01-30
JPH06271471A (ja) 1994-09-27
SG45236A1 (en) 1998-01-16
CN1101260A (zh) 1995-04-12
EP0621038B1 (en) 1998-12-02
US5534509A (en) 1996-07-09
US5658896A (en) 1997-08-19
DK0621038T3 (da) 1999-08-16
KR100294580B1 (ko) 2001-07-03
US5807951A (en) 1998-09-15
TW270085B (es) 1996-02-11
JP2588109B2 (ja) 1997-03-05
DE69414904D1 (de) 1999-01-14
EP0621038A1 (en) 1994-10-26

Similar Documents

Publication Publication Date Title
ES2127302T3 (es) Composiciones farmaceuticas que incluyen polimeros en silicato.
CA2107709A1 (en) Calcium Agent for Plants
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
AU4874897A (en) Heterocycle derivatives
ATE103808T1 (de) N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
DE59405376D1 (de) Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
FR2719769B1 (fr) Composition cosmétique ou dermatologique sous forme d'huile gélifiée contenant un mélange d'acide hydroxy-12 stéarique ou d'un dialkylamide de l'acide N-lauroylglutamique et d'un copolymère styrène/alcadiène hydrogéné.
DE69939721D1 (de) Fulvinsäure und deren Verwendung in der Behandlung von Candida Infektionen
NO307464B1 (no) Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter
ES2169272T3 (es) Diaminopirimidinas, composiciones farmaceuticas que las contienen y su utilizacion como agente antibacteriano.
PT727996E (pt) Formulacoes de febbendazol
MX9300336A (es) Procedimiento para la reduccion del contenido de formaldehido en formulaciones de microcapsula.
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
DE58903964D1 (de) Fluessige orale formulierung.
ES2118824T3 (es) Composiciones oftalmicas a base de acido poliacrilico.
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
NO892495D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparat.
ATE106407T1 (de) Derivate von thiazolidin-4-carbonsäure, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3782434D1 (de) Kovalent gebundene mittel mit kohlenstoffionen-gruppen.
DE69427949D1 (de) Acriflavine enthaltende Arzneimittel verwendbar zur Behandlung von Herpes und Zona
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
KR880012228A (ko) 천식 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621038

Country of ref document: ES